APA (7th ed.) Citation

Pommert, L., Schafer, E. S., Malvar, J., Gossai, N., Florendo, E., Pulakanti, K., . . . Burke, M. J. (2022). Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. American journal of hematology, 97(5), 613-622. https://doi.org/10.1002/ajh.26510

Chicago Style (17th ed.) Citation

Pommert, Lauren, et al. "Decitabine and Vorinostat with FLAG Chemotherapy in Pediatric Relapsed/refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium." American Journal of Hematology 97, no. 5 (2022): 613-622. https://doi.org/10.1002/ajh.26510.

MLA (9th ed.) Citation

Pommert, Lauren, et al. "Decitabine and Vorinostat with FLAG Chemotherapy in Pediatric Relapsed/refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium." American Journal of Hematology, vol. 97, no. 5, 2022, pp. 613-622, https://doi.org/10.1002/ajh.26510.